You just read:

Breakthrough in Alzheimer's Disease: AFFiRiS Halted Clinical Progression in Alzheimer Patients Upon Treatment With AD04 in a Phase II Clinical Study

News provided by

AFFiRiS AG

Jun 04, 2014, 05:00 ET